Strong Buy with Speculative Risk...um...yep...seems fair
Great to get this article out there. Clearly calls out the potential of the immuno-oncology space and the exciting potential if lightning ever actually lands in the bottle. The 20.75 valuation that is put on the stock (about $26 CDN) is based on the current stage and feelings. I think that the other math that is noted and the back of envelope division that one may do can lead them to 3-figure stock price with the current number of outstanding shares. Highly speculative but there is certainly something to be giddy about on this fine Monday. Best to all HNG